September 22, 2017
3 min watch

VIDEO: CXL becoming first-line therapy for keratoconus

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

LAS VEGAS – Corneal collagen cross-linking is quickly becoming the first line of treatment for progressive keratoconus, Clark Chang, OD, director of specialty contact lens, Wills Eye Hospital, and director of clinical services, TLC Vision, said here at Vision Expo West.

While the current treatment does not offer refractive correction, CXL with topography-guided PRK and photorefractive intrastromal CXL (under study) may address low refractive errors.